ProCE Banner Activity

GEMINI-1 and -2: Subgroup Analyses Consistent With Overall Safety and Efficacy Findings for DTG + 3TC in ART-Naive Adults at Wk 96

Slideset Download
Conference Coverage
Among patients initiating dual therapy, virologic suppression rates maintained regardless of stratification by age, sex, race, and baseline HIV-1 RNA level or CD4+ cell count.

Released: October 31, 2019

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare